(Q37058764)

18 August 2017

1 reference

title

Erectile dysfunction as a harbinger for increased cardiometabolic risk (English)

1 reference

18 August 2017

1 reference

K L Billups

1

1 reference

18 August 2017

A J Bank

2

1 reference

18 August 2017

H Padma-Nathan

3

1 reference

18 August 2017

S D Katz

4

1 reference

18 August 2017

R A Williams

5

1 reference

18 August 2017

publication date

17 January 2008

1 reference

International Journal of Impotence Research

18 August 2017

published in

1 reference

18 August 2017

volume

20

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

236-242

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ijir.3901634

18 August 2017

exact match

0 references

cites work

Platelets, oxidant stress and erectile dysfunction: an hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Oxygen free radicals and the penis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Coronary heart disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Physiology, genetics, and cardiovascular disease: focus on African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Smoking cessation strategies for the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Diagnosis, prevention, and intervention for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Abdominal adiposity and clustering of multiple metabolic syndrome in White, Black and Hispanic americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Prevalence of premature ejaculation: a global and regional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Management of peripheral arterial disease in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Peripheral arterial disease: epidemiology and drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Peak systolic velocity in patients with arterial erectile dysfunction and peripheral arterial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Comparative study between corpus cavernosum-electromyography findings and electron microscopy of cavernosal muscle biopsies in erectile dysfunction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Cardiovascular disease: different strategies for primary and secondary prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Vasodilation in black Americans: attenuated nitric oxide-mediated responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Comparison of metabolic vasodilation in response to exercise and ischemia and endothelium-dependent flow-mediated dilation in African-American versus non-African-American patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

7 January 2021

Erectile dysfunction and subsequent cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

7 January 2021

Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

7 January 2021

The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

7 January 2021

Follow-up report on the diagnosis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

7 January 2021

Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

7 January 2021

Incidence of extragenital vascular disease in patients with erectile dysfunction of arterial origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

7 January 2021

The process of care model for evaluation and treatment of erectile dysfunction. The Process of Care Consensus Panel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

1 reference

7 January 2021

Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

7 January 2021

Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901634

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3901634

1 reference

18 August 2017

1 reference